Inhibikase Therapeutics, Inc. is the market’s most crowded short at 31.1 days to cover
19.6M shares of IKT are held short against an average day’s volume that would take 31.1 sessions to absorb. Positioning this crowded is fuel, not a forecast: heavily shorted names frequently keep falling, and the full page carries the history that says which this one has been doing.